摘要
目的研究分析复方鳖甲软肝片联合恩替卡韦治疗慢性乙肝早期肝硬化的临床效果。方法选取2014年3月—2015年3月收治的慢性乙肝早期肝硬化患者110例,所有患者按照入院顺序均分为对照组和观察组,每组各55例。对照组患者口服恩替卡韦,观察组患者在对照组的基础上联合复方鳖甲软肝片进行治疗。观察两组临床治疗效果以及治疗前后肝功能指标改善情况,进行分析对比。结果观察组治疗总有效率98.2%明显要比对照组的76.4%高,差异具有统计学意义(P<0.05),通过治疗后,观察组和对照组肝功能指标改善情况明显要优于治疗前,且观察组肝功能指标改善情况明显要优于对照组,差异具有统计学意义(P<0.05)。结论慢性乙肝早期肝硬化患者应用复方鳖甲软肝片联合恩替卡韦进行治疗具有显著的治疗效果,有效改善肝功能指标,充分提高患者的生活质量,值得在临床应用中广泛推广。
Objective To study the clinical effect of compound Biejia Ruangan tablets combined with entecavir in the treatment of chronic hepatitis B with early liver cirrhosis. Methods Selecting 110 cases of patients with chronic hepatitis B with early liver cirrhosis in our hospital from March 2014 to March 2015, they were divided into control group and observation group in chronological order, and each group had 55 cases. The control group was treated with entecavir. The observation group received compound Biejia Ruangan tablets based on the control group. The clinical therapeutic effect and liver function indicators of the two groups before and after treatment were ob-served and compared. Results The total effective rate of the observation group was 98.2% which was significantly higher than 76.4% of the the control group, and the difference was statistically significant（ P〈0.05）. After treatment, the liver function of the observation group and control group improved significantly than those before treatment, the observation group improved significantly better than the control group, and the difference was statistically significant（ P〈0.05）. Conclusion The compound Biejia Ruangan tablets combined with entecavir in the treatment of chronic hepatitis B with early liver cirrhosis has significant therapeutic effect, can effectively improve liver function indicators, fully improve the quality of life of patients, and is worthy of popularization in clinical application.
出处
《中国中医药现代远程教育》
2015年第24期136-137,共2页
Chinese Medicine Modern Distance Education of China
关键词
复方鳖甲软肝片
恩替卡韦
慢性乙肝早期肝硬化
中西医结合疗法
compound Biejia Ruangan tablets
entecavir
chronic hepatitis B with early liver cirrhosis
therapy of integrated medicine
